Outcomes following cataract surgery in choroideremia
TL Edwards, M Groppe, RE MacLaren
Eye | NATURE PUBLISHING GROUP | Published : 2015
Awarded by National Institute for Health Research
REM is a Director of NightstarX Ltd (215 Euston Road, London, UK NW1 2BE), a choroideremia gene therapy company established and funded by the Wellcome Trust. The remaining authors declare no conflict of interest.